“Exogenous administration of protectin (PD)1n-3 DPA or resolvin (Rv)D5n-3 DPA in mice reduced dextran sulfate sodium-induced colitis though a mechanism partly linked to decreased leukocyte–endothelial interaction and reduced granulocyte trafficking, as assessed by intravital microscopy.”